NDC 82448-134 – Gomekli
Mirdametinib 1 mg/1 · Tablet, For Suspension · Oral
Product NDC82448-134
Product details
- Brand name
- Gomekli
- Generic name
- mirdametinib
- Labeler
- SpringWorks Therapeutics, Inc.
- Dosage form
- Tablet, For Suspension
- Route
- Oral
- Marketing category
- NDA · NDA219379
- Marketed since
- February 11, 2025
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Mirdametinib 1 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 82448-134-42 | 42 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-42) | Feb 11, 2025 |
| 82448-134-84 | 84 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-84) | Feb 11, 2025 |